Chalazion and hordeolum associated with Elexacaftor-Tezacaftor-Ivacaftor use in children with cystic fibrosis.

Saved in:
Bibliographic Details
Title: Chalazion and hordeolum associated with Elexacaftor-Tezacaftor-Ivacaftor use in children with cystic fibrosis.
Authors: Liew C; Leeds Teaching Hospitals NHS Trust, Leeds LS1 3EX, UK., Brookes A; York and Scarborough NHS Trust, York YO31 8HE, UK., Guy EL; Leeds Teaching Hospitals NHS Trust, Leeds LS1 3EX, UK., Wisby L; Betsi Cadwaladr University Health Board, Wales LL18 5UJ, UK., Mayell SJ; Alder Hey Children's Hospital NHS Trust, Liverpool L14 5AB, UK., Walker LC; Leeds Teaching Hospitals NHS Trust, Leeds LS1 3EX, UK., Lee TW; Leeds Teaching Hospitals NHS Trust, Leeds LS1 3EX, UK. Electronic address: tim.lee1@nhs.net.
Source: Respiratory medicine and research [Respir Med Res] 2026 May; Vol. 89, pp. 101268. Date of Electronic Publication: 2026 Mar 30.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Masson SAS Country of Publication: France NLM ID: 101746324 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2590-0412 (Electronic) Linking ISSN: 25900412 NLM ISO Abbreviation: Respir Med Res Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:2590-0412
DOI:10.1016/j.resmer.2026.101268